Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/131770
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAngelo Carpi, Carlo Donadio and Gianfranco Tramonti
dc.date.accessioned2017-04-30T13:33:25Z-
dc.date.available2017-04-30T13:33:25Z-
dc.date.issued2011
dc.identifier.isbn978-953-307-377-4
dc.identifier.urihttp://hdl.handle.net/123456789/131770-
dc.description.abstractHemodialysis (HD) represents the first successful long-term substitutive therapy with an artificial organ for severe failure of a vital organ. Because HD was started many decades ago, a book on HD may not appear to be up-to-date. Indeed, HD covers many basic and clinical aspects and this book reflects the rapid expansion of new and controversial aspects either in the biotechnological or in the clinical field. This book revises new technologies and therapeutic options to improve dialysis treatment of uremic patients. This book consists of three parts: modeling, methods and technique, prognosis and complications.
dc.language.isoeng
dc.publisherInTech
dc.relation.isbasedon10.5772/878
dc.relation.urihttp://www.intechopen.com/books/progress-in-hemodialysis-from-emergent-biotechnology-to-clinical-practice
dc.rights.uriCC by (姓名標示)
dc.sourceInTech
dc.subject.classificationMedicine
dc.subject.classification Urology and Nephrology
dc.titleProgress in Hemodialysis - From Emergent Biotechnology to Clinical Practice
dc.type電子教課書
dc.classification醫學類
Theme:教科書-醫學類

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.